Delta Emerald Ventures is a New York-based venture capital firm specializing in cannabis and cannabinoid industry investments. The firm leverages proprietary data and behavioral insights to invest in cannabis ecosystem technology, including retail, production, brands, distribution, and cannabinoid technology.
Their most common stage is series-a (45% of deals). Average disclosed round size is $20.8M (across 10 rounds with reported amounts).
Portfolio
10
Fund Size
—
Top Stage
Series A
Last 12 Mo
0
Team
AD
Adam Dawson
Director
MS
Michael Smith
Principal
ID
Ian Dominguez
Founder
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
11 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 Happy Cabbage | Unknown | — | Nov 2022 |
 Vangst | Series B | $19M | Jan 2022 |
 Cellibre | Series A | $11.5M | Oct 2021 |
 Jane Technologies | Series C | $100M | Aug 2021 |
 Adaviv | Seed | $2.3M | Jul 2021 |
 Henry's Original | Series B | $11M | Aug 2019 |
| Jane Technologies | Series B | $21M | Jul 2019 |
 BRC Therapeutics | Series A | $20M | — |
 Uncle Arnie's | Series A | $7.5M | — |
 Blaze | Series A | $8M | — |
| BBLAZE | Series A | $8M | — |
Top Co-Investors
Merida Capital Holdings3 shared
Poseidon Asset Management2 shared
Gotham Green Partners2 shared
Act One Ventures2 shared
Scale Venture Partners1 shared
Greenoaks Capital1 shared
Third Point Ventures1 shared
The Artemis Fund1 shared
L2 Ventures1 shared
Phyto Partners1 shared
Casa Verde Capital1 shared
Level One Fund1 shared
Lerer Hippeau1 shared
Information Venture Partners1 shared
Entourage Effect Capital1 shared
JW Asset Management1 shared
New Stack1 shared
Palo Santo1 shared
AFI Capital Partners1 shared
Argonautic Ventures1 shared
Last updated: 8 September 2026